Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)

被引：0
|
作者：
Kapustin, J. [1 ]
Anderson, J. E. [2 ]
Reid, T. [3 ]
Rhinehart, A. [4 ]
Brunton, S. [5 ]
Stewart, J. [6 ]
Zhou, W. [6 ]
Dex, T. [7 ]
Kazemi, M. [7 ]
Vlajnic, A. [7 ]
Dalal, M. [7 ]
机构：
[1] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA
[2] Frist Cliln, Nashville, TN USA
[3] Mercy Diabet Ctr, Janesville, WI USA
[4] Johnston Mem Diabet Care Ctr, Abingdon, VA USA
[5] Primary Care Educ Consortium, Charlotte, NC USA
[6] Sanofi Canada, Laval, PQ, Canada
[7] Sanofi US, Bridgewater, MA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1070
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [21] Psychosocial adjustment and outcomes of glycaemic control with basal insulin therapy in patients with type 2 diabetes mellitus (T2DM)
    Tanenberg, R. J.
    Zhang, Q.
    Zisman, A.
    DIABETOLOGIA, 2007, 50 : S435 - S436
  • [22] Now or Later? Real-World Study of Impact of Timing of Insulin Initiation on Outcomes Among Elderly Medicare Patients With Type 2 Diabetes Mellitus (T2DM)
    Sambamoorthi, Usha
    Wei, Wenhui
    Zhou, Steve
    Bhattacharya, Rituparna
    Ling, John
    Ajmera, Mayank
    DIABETES, 2013, 62 : A317 - A317
  • [23] Real-World (RW) Glycemic Control and Medication Adherence among Patients with Type 2 Diabetes Mellitus (T2DM) Initiated on Canagliflozin
    Jain, Rahul
    Cai, Jennifer
    Fu, An-Chen
    Chow, Wing
    Tan, Hiangkiat
    DIABETES, 2016, 65 : A304 - A305
  • [24] Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Ellison, Misoo C.
    Pong, Annpey
    Huyck, Susan
    Mancuso, James P.
    Terra, Steven G.
    Gantz, Ira
    DIABETES, 2019, 68
  • [25] REAL-WORLD INSULIN THERAPY IN GERMAN TYPE 2 DIABETES MELLITUS PATIENTS: PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND INSULIN DOSAGE
    Gabler, M.
    Geier, S.
    Foersch, J.
    Picker, N.
    Mueller, S.
    Aberle, J.
    Martin, S.
    Riedl, M.
    Wilke, T.
    VALUE IN HEALTH, 2019, 22 : S594 - S595
  • [26] Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
    Wilke, Thomas
    Picker, Nils
    Mueller, Sabrina
    Geier, Silke
    Foersch, Johannes
    Aberle, Jens
    Martin, Stephan
    Riedl, Matthias
    Gabler, Maximilian
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1225 - 1237
  • [27] Real-World Persistence with GLP-1 RA Treatment in Patients with Type 2 Diabetes Mellitus (T2DM) and Advanced Chronic Kidney Disease (CKD)
    Sidra, Fnu
    Xie, Donglu
    Agarwal, Shubham
    Lingvay, Ildiko
    DIABETES, 2023, 72
  • [28] Trends in Medication Use in Patients with Type 2 Diabetes Mellitus (T2DM): A Long-Term View of Real-World Treatment between 2000 and 2015
    Higgins, Victoria
    Leith, Andrea
    Siddall, James
    Gillespie, Alexander
    Benford, Michael
    DIABETES, 2016, 65 : A91 - A91
  • [29] PATTERNS OF TREATMENT ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING LINAGLIPTIN AND OTHER NON-INSULIN DIABETES MEDICATIONS (NIDMS)
    Patorno, E.
    Gopalakrishnan, C.
    Zorina, O.
    Schneeweiss, S.
    Bartels, D.
    Seeger, J. D.
    VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
  • [30] Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
    Shafie, Asrul Akmal
    Ng, Chin Hui
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 333 - 343
12345